SAN DIEGO, Jan. 23, 2020 (GLOBE NEWSWIRE) — Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation […]
JERUSALEM, Jan. 23, 2020 (GLOBE NEWSWIRE) — LipoMedix, a clinical-stage, oncology-focused pharmaceutical company, involved in the development of innovative, safe […]